KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Long-Term Deferred Tax (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Long-Term Deferred Tax for 15 consecutive years, with $18.4 billion as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 11.93% to $18.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.4 billion through Dec 2025, up 11.93% year-over-year, with the annual reading at $18.4 billion for FY2025, 11.93% up from the prior year.
  • Long-Term Deferred Tax hit $18.4 billion in Q4 2025 for Abbott Laboratories, up from $17.3 billion in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $18.4 billion in Q4 2025 to a low of $3.7 billion in Q1 2021.
  • Historically, Long-Term Deferred Tax has averaged $8.8 billion across 5 years, with a median of $6.5 billion in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: rose 7.95% in 2021 and later soared 131.91% in 2024.
  • Year by year, Long-Term Deferred Tax stood at $5.2 billion in 2021, then rose by 15.75% to $6.0 billion in 2022, then rose by 17.64% to $7.1 billion in 2023, then skyrocketed by 131.91% to $16.5 billion in 2024, then increased by 11.93% to $18.4 billion in 2025.
  • Business Quant data shows Long-Term Deferred Tax for ABT at $18.4 billion in Q4 2025, $17.3 billion in Q3 2025, and $17.3 billion in Q2 2025.